{"id":263819,"date":"2026-09-23T11:33:31","date_gmt":"2026-09-23T06:03:31","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=263819"},"modified":"2026-09-23T11:33:31","modified_gmt":"2026-09-23T06:03:31","slug":"poly-medicure-stock-signals-investors-are-watching","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/","title":{"rendered":"Poly Medicure: 7 Stock Signals Investors Are Watching Right Now"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Poly Medicure CMP Rs 1,717.20. 52W range Rs 1,182.00-2,094.30. Mcap Rs 17,224 crore. PE 55.05 vs sector 68.95.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Poly Medicure stock signals right now span an earnings picture, a shareholding pattern where promoter holding promoter and institutional shareholding figures were not available from the data source used here; investors can check the company&#8217;s latest exchange filing directly, and a technical setup where the stock trades well off its 52-week low of Rs 1,182.00. Debt to equity stands at 0.11, and valuation sits at a P\/E of 55.05 against a sector average of 68.95. Corporate developments in the medical devices manufacturing space add further context investors are tracking alongside these numbers. None of the seven signals here amounts to a buy or sell call on its own.<\/p>\n<\/p><\/div>\n<p>Poly Medicure stock signals are unusually layered right now, with the company trading at Rs 1,717.20, 18.0% below its 52-week high of Rs 2,094.30 and 45.3% above its 52-week low of Rs 1,182.00. Poly Medicure is a well tracked name in the medical devices manufacturing space, and no single headline captures where the stock stands today.<\/p>\n<p>This article does not make a buy, hold or sell call on Poly Medicure. It lays out seven signals investors commonly watch, each sourced from the company&#8217;s latest exchange disclosures and financial statements, so readers can form their own view of what is currently working for the stock and what still needs to be watched.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=poly-medicure-stock-signals-investors-are-watching\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#Poly_Medicure_Stock_at_a_Glance\" title=\"Poly Medicure Stock at a Glance\">Poly Medicure Stock at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#1_Earnings_Trend_at_Poly_Medicure\" title=\"1. Earnings Trend at Poly Medicure\">1. Earnings Trend at Poly Medicure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#2_FII_Holding_in_Poly_Medicure\" title=\"2. FII Holding in Poly Medicure\">2. FII Holding in Poly Medicure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#3_Promoter_Holding_in_Poly_Medicure\" title=\"3. Promoter Holding in Poly Medicure\">3. Promoter Holding in Poly Medicure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#4_Debt_Position_at_Poly_Medicure\" title=\"4. Debt Position at Poly Medicure\">4. Debt Position at Poly Medicure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#5_Valuation_of_Poly_Medicure_Shares\" title=\"5. Valuation of Poly Medicure Shares\">5. Valuation of Poly Medicure Shares<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#6_Technical_Trend_on_the_Poly_Medicure_Chart\" title=\"6. Technical Trend on the Poly Medicure Chart\">6. Technical Trend on the Poly Medicure Chart<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#7_Corporate_Developments_at_Poly_Medicure\" title=\"7. Corporate Developments at Poly Medicure\">7. Corporate Developments at Poly Medicure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#What_These_Poly_Medicure_stock_signals_Mean_Together\" title=\"What These Poly Medicure stock signals Mean Together\">What These Poly Medicure stock signals Mean Together<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#FAQs_on_Poly_Medicure_Stock_Signals\" title=\"FAQs on Poly Medicure Stock Signals\">FAQs on Poly Medicure Stock Signals<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#Why_is_Poly_Medicure_share_price_where_it_is_right_now\" title=\"Why is Poly Medicure share price where it is right now?\">Why is Poly Medicure share price where it is right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#What_is_Poly_Medicures_current_FII_holding\" title=\"What is Poly Medicure&#8217;s current FII holding?\">What is Poly Medicure&#8217;s current FII holding?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#Is_Poly_Medicures_debt_position_a_concern_right_now\" title=\"Is Poly Medicure&#8217;s debt position a concern right now?\">Is Poly Medicure&#8217;s debt position a concern right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#What_is_the_promoter_holding_in_Poly_Medicure\" title=\"What is the promoter holding in Poly Medicure?\">What is the promoter holding in Poly Medicure?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#Is_Poly_Medicure_expensive_compared_to_its_sector\" title=\"Is Poly Medicure expensive compared to its sector?\">Is Poly Medicure expensive compared to its sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#What_recent_corporate_developments_are_relevant_to_Poly_Medicure\" title=\"What recent corporate developments are relevant to Poly Medicure?\">What recent corporate developments are relevant to Poly Medicure?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#What_do_the_technical_charts_suggest_about_Poly_Medicure_right_now\" title=\"What do the technical charts suggest about Poly Medicure right now?\">What do the technical charts suggest about Poly Medicure right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/poly-medicure-stock-signals-investors-are-watching\/#Should_investors_buy_Poly_Medicure_shares_at_current_levels\" title=\"Should investors buy Poly Medicure shares at current levels?\">Should investors buy Poly Medicure shares at current levels?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Poly_Medicure_Stock_at_a_Glance\"><\/span><strong>Poly Medicure Stock at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Before going through each of the seven Poly Medicure stock signals in detail, the snapshot below sets the starting point on price, valuation and balance sheet strength.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"text-align:left;border-bottom:1px solid #ddd;padding:6px;\">Metric<\/th>\n<th style=\"text-align:left;border-bottom:1px solid #ddd;padding:6px;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:6px;\"><a href=\"https:\/\/univest.in\/stocks\/polymed\/poly-medicure-ltd-share-price-today\">Poly Medicure<\/a> CMP<\/td>\n<td style=\"padding:6px;\">Rs 1,717.20 (NSE, 23 Sep 2026)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:6px;\">52-Week High<\/td>\n<td style=\"padding:6px;\">Rs 2,094.30 (10 November 2025)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:6px;\">52-Week Low<\/td>\n<td style=\"padding:6px;\">Rs 1,182.00 (30 March 2026)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:6px;\">Market Capitalisation<\/td>\n<td style=\"padding:6px;\">Rs 17,224 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:6px;\">P\/E Ratio<\/td>\n<td style=\"padding:6px;\">55.05 (Sector P\/E 68.95)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:6px;\">P\/B Ratio<\/td>\n<td style=\"padding:6px;\">5.55<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:6px;\">Debt to Equity<\/td>\n<td style=\"padding:6px;\">0.11<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:6px;\">Return on Equity<\/td>\n<td style=\"padding:6px;\">10.37%<\/td>\n<\/tr>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"1_Earnings_Trend_at_Poly_Medicure\"><\/span><strong>1. Earnings Trend at Poly Medicure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Poly Medicure posted trailing-twelve-month revenue of Rs 2,109 crore versus Rs 1,995 crore a year earlier, while net profit moved to Rs 313 crore from Rs 321 crore, a change of -2.4% on the year. The most recent quarter added Rs 558.79 crore in revenue, a change of 25.5% year on year, against Rs 85.27 crore in net profit versus Rs 93.08 crore a year earlier.<\/p>\n<p>net profit was down close to 8% year on year in the June 2026 quarter even as revenue grew over 25%, with trailing-twelve-month profit down close to 2% versus a year earlier. This is the first of the seven Poly Medicure stock signals worth tracking closely into the next results.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"2_FII_Holding_in_Poly_Medicure\"><\/span><strong>2. FII Holding in Poly Medicure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A full quarterly FII holding series was not available from the data source used here for Poly Medicure. Where that is the case, the most reliable next step is to check the company&#8217;s latest exchange filing directly, since a single-quarter snapshot can be misleading without the trend around it.<\/p>\n<p>This is worth revisiting once the next quarterly shareholding disclosure is filed.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"3_Promoter_Holding_in_Poly_Medicure\"><\/span><strong>3. Promoter Holding in Poly Medicure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Promoter holding in Poly Medicure promoter and institutional shareholding figures were not available from the data source used here; investors can check the company&#8217;s latest exchange filing directly.<\/p>\n<p>This is worth revisiting once the next quarterly shareholding disclosure is filed, to see whether the level and direction of change persists.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"4_Debt_Position_at_Poly_Medicure\"><\/span><strong>4. Debt Position at Poly Medicure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Poly Medicure&#8217;s debt to equity ratio stands at 0.11, one of the balance sheet metrics worth tracking alongside the earnings trend above. A lower or stable ratio generally gives more room to fund growth without leaning further on external borrowing, while a rising one is worth watching for its effect on finance costs.<\/p>\n<p>This debt signal should be read alongside the valuation and corporate development signals below rather than in isolation, since capital raising plans can shift the picture from one quarter to the next.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Valuation_of_Poly_Medicure_Shares\"><\/span><strong>5. Valuation of Poly Medicure Shares<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At the current price, Poly Medicure trades at a price to earnings ratio of 55.05, a discount of close to 20.2% versus the sector average of 68.95. The price to book ratio stands at 5.55.<\/p>\n<p>Whether that discount looks justified depends on the earnings trend from Signal 1 continuing, and it is one of the clearer places where the seven signals can pull in different directions at the same time.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"6_Technical_Trend_on_the_Poly_Medicure_Chart\"><\/span><strong>6. Technical Trend on the Poly Medicure Chart<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock last traded around Rs 1,717.20, above its short-term average of about Rs 1,700.47, pointing to near-term strength. The 14-day RSI reads close to 50, in neutral territory. The MACD line sits above its signal line, a bullish momentum bias.<\/p>\n<p>Over the past year the stock is currently 18.0% below its 52-week high of Rs 2,094.30 and 45.3% above its 52-week low of Rs 1,182.00. A sustained move back above its recent average would be an early technical sign of stabilisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"7_Corporate_Developments_at_Poly_Medicure\"><\/span><strong>7. Corporate Developments at Poly Medicure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Poly Medicure manufactures a diverse portfolio of medical devices spanning infusion therapy, oncology, anaesthesia and respiratory care, urology, dialysis, blood management and wound drainage products, supplying both the Indian and international markets.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live fundamentals<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_These_Poly_Medicure_stock_signals_Mean_Together\"><\/span><strong>What These Poly Medicure stock signals Mean Together<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>None of these seven signals on its own settles the debate on Poly Medicure. Reading them as a set, rather than picking out any single one, is the more balanced way to approach the stock right now. The earnings trend, shareholding pattern, balance sheet position, valuation, technical setup and corporate developments each add one piece of the picture, and they do not all point the same way at the same time.<\/p>\n<p>Investors weighing Poly Medicure would do well to watch the next quarterly results for a read on where margins and profit are heading, alongside the next shareholding pattern update for any shift in institutional positioning. Reading these Poly Medicure stock signals together, rather than in isolation, remains the more balanced approach. As with any single stock, price movements can be volatile and past trends do not guarantee future performance.<\/p>\n<p>For context, investors following Poly Medicure often look at how the stock has moved through previous earnings cycles, how peer companies in the same space have reacted to similar corporate developments, and whether broader market conditions such as interest rate moves, sector-wide policy shifts or commodity price swings have played a larger role than company-specific news. None of these broader factors replace the seven signals above, but they help explain why a stock can move sharply even when no single company-specific trigger is visible in the data. Reading a stock&#8217;s price action purely in isolation, without this wider lens, can lead to drawing conclusions that do not hold up once the next quarter&#8217;s numbers or the next shareholding disclosure comes in. Investors are generally better served treating each of these seven factors as one input among several, updated on a rolling basis as new disclosures arrive, rather than as a one-time checklist filled in once and then set aside for the rest of the year without a further look.<\/p>\n<p style=\"margin-top:24px;\"><em>Also Read: <a href=\"https:\/\/univest.in\/blogs\/hdfc-bank-stock-signals-investors-are-watching\/\">HDFC Bank: 7 Stock Signals Investors Are Watching Right Now<\/a><\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Poly Medicure currently sits at the intersection of several moving parts, from earnings and shareholding to valuation and chart trend, and that is exactly what the seven signals above are meant to surface. This article does not recommend buying, holding or selling Poly Medicure shares, and readers should form their own view based on their own research and risk appetite.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Poly Medicure live price and more such signal based stock research.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information and the company&#8217;s exchange filings. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Poly_Medicure_Stock_Signals\"><\/span><strong>FAQs on Poly Medicure Stock Signals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Poly_Medicure_share_price_where_it_is_right_now\"><\/span><strong>Why is Poly Medicure share price where it is right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Poly Medicure shares are trading 18.0% below their 52-week high of Rs 2,094.30 and 45.3% above their 52-week low of Rs 1,182.00, shaped by the earnings trend, shareholding shifts and technical setup covered in this article, rather than any single factor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Poly_Medicures_current_FII_holding\"><\/span><strong>What is Poly Medicure&#8217;s current FII holding?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A full quarterly FII holding series was not available for this article; check the company&#8217;s latest exchange filing directly.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Poly_Medicures_debt_position_a_concern_right_now\"><\/span><strong>Is Poly Medicure&#8217;s debt position a concern right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The debt to equity ratio stands at 0.11.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_promoter_holding_in_Poly_Medicure\"><\/span><strong>What is the promoter holding in Poly Medicure?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> promoter and institutional shareholding figures were not available from the data source used here; investors can check the company&#8217;s latest exchange filing directly.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Poly_Medicure_expensive_compared_to_its_sector\"><\/span><strong>Is Poly Medicure expensive compared to its sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Poly Medicure trades at a price to earnings ratio of 55.05 against a sector average of 68.95.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_recent_corporate_developments_are_relevant_to_Poly_Medicure\"><\/span><strong>What recent corporate developments are relevant to Poly Medicure?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Poly Medicure manufactures a diverse portfolio of medical devices spanning infusion therapy, oncology, anaesthesia and respiratory care, urology, dialysis, blood management and wound drainage products, supplying both the Indian and international markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_technical_charts_suggest_about_Poly_Medicure_right_now\"><\/span><strong>What do the technical charts suggest about Poly Medicure right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock is trading above its short-term average of about Rs 1,700.47, pointing to near-term strength, with its MACD line above its signal line, a bullish momentum bias.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_buy_Poly_Medicure_shares_at_current_levels\"><\/span><strong>Should investors buy Poly Medicure shares at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article does not offer a buy, hold or sell recommendation. It lays out seven Poly Medicure stock signals, earnings, FII holding, promoter holding, debt, valuation, technicals and corporate developments, so investors can weigh each signal and form their own view based on their goals and risk appetite.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Poly Medicure share price where it is right now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Poly Medicure shares are trading 18.0% below their 52-week high of Rs 2,094.30 and 45.3% above their 52-week low of Rs 1,182.00, shaped by the earnings trend, shareholding shifts and technical setup covered in this article, rather than any single factor.\"}},{\"@type\":\"Question\",\"name\":\"What is Poly Medicure's current FII holding?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A full quarterly FII holding series was not available for this article; check the company's latest exchange filing directly.\"}},{\"@type\":\"Question\",\"name\":\"Is Poly Medicure's debt position a concern right now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The debt to equity ratio stands at 0.11.\"}},{\"@type\":\"Question\",\"name\":\"What is the promoter holding in Poly Medicure?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"promoter and institutional shareholding figures were not available from the data source used here; investors can check the company's latest exchange filing directly.\"}},{\"@type\":\"Question\",\"name\":\"Is Poly Medicure expensive compared to its sector?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Poly Medicure trades at a price to earnings ratio of 55.05 against a sector average of 68.95.\"}},{\"@type\":\"Question\",\"name\":\"What recent corporate developments are relevant to Poly Medicure?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Poly Medicure manufactures a diverse portfolio of medical devices spanning infusion therapy, oncology, anaesthesia and respiratory care, urology, dialysis, blood management and wound drainage products, supplying both the Indian and international markets.\"}},{\"@type\":\"Question\",\"name\":\"What do the technical charts suggest about Poly Medicure right now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock is trading above its short-term average of about Rs 1,700.47, pointing to near-term strength, with its MACD line above its signal line, a bullish momentum bias.\"}},{\"@type\":\"Question\",\"name\":\"Should investors buy Poly Medicure shares at current levels?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This article does not offer a buy, hold or sell recommendation. It lays out seven Poly Medicure stock signals, earnings, FII holding, promoter holding, debt, valuation, technicals and corporate developments, so investors can weigh each signal and form their own view based on their goals and risk appetite.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Poly Medicure stock signals right now: earnings, FII holding, promoter stake, debt, valuation, technical trend and corporate developments, all in one place, with no buy or sell call.<\/p>\n","protected":false},"author":29,"featured_media":263817,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[6759,1019],"class_list":["post-263819","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-medical-devices-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["263817"],"rank_math_title":["Poly Medicure Stock Signals to Watch This Week"],"rank_math_description":["Earnings, FII holding, promoter stake, debt, valuation, technicals and corporate developments now shaping Poly Medicure stock signals for investors."],"rank_math_focus_keyword":["Poly Medicure stock signals"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/poly-medicure-7-stock-signals-investors-are-watching-right-now.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/263819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=263819"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/263819\/revisions"}],"predecessor-version":[{"id":263821,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/263819\/revisions\/263821"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/263817"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=263819"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=263819"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=263819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}